Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial-Reference-Cited by-同舟云学术

Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial

Published:2023-08 Issue:8 Volume:24 Page:892-902
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Blay Jean-Yves,Chevret Sylvie,Le Cesne Axel,Brahmi Mehdi,Penel Nicolas,Cousin Sophie,Bertucci Francois,Bompas Emmanuelle,Ryckewaert Thomas,Soibinet Pauline,Boudou-Rouquette Pascaline,Saada Bouzid Esma,Soulie Patrick,Valentin Thibaud,Lotz Jean-Pierre,Tosi Diego,Neviere Zoé,Cancel Mathilde,Ray-Coquard Isabelle,Gambotti Laetitia,Legrand Frédéric,Lamrani-Ghaouti Assia,Simon Clotilde,Even Caroline,Massard Christophe

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network;de Pinieux;PLoS One,2021

2. Improving at a nationwide level the management of patients with sarcomas with an expert network;Blay;Ann Oncol,2022

3. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up;Gronchi;Ann Oncol,2021

4. Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities;Stacchiotti;Cancer,2021

5. Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy;Blay;Eur J Cancer,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

2. Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy;eBioMedicine;2024-08

3. Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics;Frontiers in Cell and Developmental Biology;2024-07-30

4. Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510);Cancer;2024-07-30

5. Long Duration Pembrolizumab for Metastatic Undifferentiated Pleomorphic Soft Tissue Sarcoma With Multimodality Therapy;Journal of Medical Cases;2024-07